Q1 2026 earnings call recap: revenue, EPS, ARR, AI innovation, ShareFile integration, churn risks, and 2026 guidance—read now.

Explore the significance of drug–target interactions in drug discovery and the challenges of fragmented data in research.

Insurers commonly layer new tools onto legacy processes, bolt pilots onto fragmented data estates, or conceive of grandiose ...

Dana (NYSE:DAN) used its Capital Markets Day to outline “Dana 2030,” a bottoms-up strategic and operating plan the company ...

Without context, sales numbers don’t mean anything,” says Armine Alajian, founder and CEO of Alajian Group Inc., an accounting firm specializing in startups ...

For months, lone vibe coder Rafael Concepcion has obsessively built tools to counter the federal immigration ...

Welcome to the earnings call of Aumann AG regarding the full year figures for 2025. The company's CEO, Sebastian Roll; and CFO, Jan-Henrik Pollitt, will guide you through the presentation and the ...

Forbes contributors publish independent expert analyses and insights. Pam Danziger reports on retail, focused on the luxury consumer market. This voice experience is generated by AI. Learn more. This ...

Target's fourth quarter 2025 net sales were 1.5% lower than the same period in 2024, and full-year sales were down 1.7%. This report was pretty much in line with company expectations and not really a ...

U.S. intelligence officials have assessed that Iranian forces have deployed a small number of mines in the Strait of Hormuz, ...

The strongest argument for a Lennar KB Home deal is neither sentiment nor brand. It is the cost structure. KB Home’s SG&A ...

Target is looking to transform in-store floor plans and displays to elevate the guest experience. Credit: Arina P Habich/Shutterstock.com. As announced at its financial community meeting on 3 March ...